Henlius Biotech holds R&D day in Shanghai
Jason Zhu, executive director and CEO of Henlius, addresses the 2025 Global R&D Day event held by the company in Shanghai on Tuesday. [Photo provided to chinadaily.com.cn] Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, …